Sub-types of cardiomyopathies | LVEF% median (range) | LVEDV (ml) median (range) | LVEDVI median(range) | LVESV (ml) median (range) | LVESVI median (range) |
---|---|---|---|---|---|
Primary dilated | 19.7 (12–54) b, c, d | 208.8 (76–412) b, c, d | 170.1 (89–338) a, b, c, d | 162.9 (53–362) b, c, d | 125.5 (41–257) b, c, d |
Secondary dilated post myocarditis | 29.5 (9–72) e | 157 (121–367) e, f | 82.6 (70–195) a, e | 101.5 (42–327) e | 56.7 (23–174) e |
Secondary dilated toxins, drugs | 43.8 (32–56) | 43.4 (32–55) | 41 (23–59) | 22.8 (22–24) | 20.7 (16–26) |
Hypertrophic | 65 (45–81) b, e | 51 (16–172) b, e | 75 (21–117) b, e | 26.4 (6–59) b, e | 26.3 (12–45) b, e |
Non-compaction | 60 (6–67) c | 63 (6–135) c, f | 66.3 (15–250) c | 24 (3–127) c | 56.7 (6–235) c |
ARVD | 42.3 (53–63) | 68.3 (53–84) | 73.8 (55–92) | 30 (29–32) | 32.3 (30–35) |
Restrictive | * | * | * | * | * |
Infiltrative thalassemia | 43.5 (21–66) d | 113.8 (16–128) d | 110.7 (18–119) d | 66 (5–96) d | 62.3 (6–94) d |
Infiltrative others | 70.2 (69–72) d | 79.5 (26–134) d | 63.6 (56–71) d | 23 (8–38) d | 18.9 (18–20) d |
Ischemic | 40.5 (35–46) | 137.5 (19–256) | 86.6 (41–132) | 75.2 (12–138) | 49 (27–71) |
Test of significance | 24.7 | 21.7 | 22.2 | 24.9 | 22.3 |
p value | 0.006* | 0.016* | 0.014* | 0.005* | 0.013* |